U.S. Markets open in 7 hrs 11 mins

Minerco, Inc. (MINE)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0019+0.0003 (+18.44%)
At close: 3:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0016
Bid0.0099 x 5000
Ask0.0140 x 5000
Day's Range0.0016 - 0.0020
52 Week Range0.0000 - 0.0480
Avg. Volume252,211,172
Market Cap17,169
Beta (5Y Monthly)46.13
PE Ratio (TTM)N/A
EPS (TTM)-0.1010
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    PSYC Enters Joint Venture Partnership with Minerco, Inc.

    PSYC Sets Sights on Expanding Its Digital Platform Within the Emerging Sector of Medicinal Psychedelics LAS VEGAS, NV, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) a digital media leader within the emerging sector of medicinal psychedelics, is pleased to announce that the Company has entered into a Joint Venture Partnership (the “JV”) with Minerco, Inc. (OTC: MINE) (“MINE”), a Jamaican-based company specializing in growing, research, production and distribution of psilocybin mushrooms and marketing worldwide. The JV creates an opportunity for the companies to collaborate on the co-development and hosting of virtual conferences and forums focused on educating, informing, and showcasing the potential medicinal benefits of psilocybin mushrooms, including the psilocybin-based products MINE is developing. Additionally, the JV allows for PSYC to serve as one of the primary digital marketing partners for MINE as they move forward with their focus of bringing their products to market. “We are extremely delighted to partner with MINE, a company that is deeply-rooted in the sector of psilocybin mushrooms,” said Global Trac Solutions, Inc. CEO, David Flores. “And we’re thrilled to be able to combine our collective resources to develop and produce virtual conferences and forums in the coming months that we believe will effectively highlight this exciting sector within the psychedelic industry.” “To JV with PSYC will be a great opportunity for both companies,” said Julius Jenge, Minerco, Inc. CEO. “MINE will have the ability to do real case studies using our own product and PSYC will be able to track the research with their media platform. This initiative will allow us to host forums with both industry experts and patients who will give real examples of the benefits of Psilocybin and more specifically MINE products.” The companies intend to be able to collectively develop and produce their first joint virtual conference/forum within the next two months and will release more information to the public related to specific dates and times as soon as it is available. “As our industry continues to gain more exposure and develop more momentum behind it, I believe we will continue to see an increase, globally, for platforms, such as Psychedelic Spotlight, that provide access to a wealth of informational and educational resources focused on this paradigm shift in healing and treatment that psychedelics like psilocybin are creating,” Flores said. “As MINE continues its focus on developing quality psilocybin-based products, we here at PSYC look forward to leveraging our expanding media platform and network to contribute to their growth and success in the months to come.” About Global Trac Solutions, Inc. (OTCPink: PSYC) At Global Trac Solutions we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters. PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream. We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow. Forward-Looking Statements Disclaimer: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website. Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly. Corporate Contact: Global Trac Solutions, Inc. (PSYC)www.globaltracsolutions.com (702) 239-1919psyc@globaltracsolutions.com OTCPINK: PSYC

  • Minerco Inc. the Magic Mushroom Company Receives 1B Valuation Pre-Money Business Valuation from EQUIDAM

    Minerco Inc. the Magic Mushroom Company Receives 1B Valuation Pre-Money Business Valuation from EQUIDAM

    Oakland, California--(Newsfile Corp. - January 19, 2021) - MINERCO Inc. (OTC Pink: MINE) has hired EQUIDAM SOFTWARE to create business valuation using 3 methods: IPEV (International Private Equity Valuation), DCF (Discounted Cash Flow) with LTG (Long Term Growth) and DCF with multiples model including the TV (Terminal Value) method. Minerco's Valuation report list IPEV at 297M, LTG AT 193M and DCF TV AT 1B. This Valuation was computed based upon financial projections ...

  • Minerco, Inc the Magic Mushroom Company Announces Sankofa Shareholder and Vision Summit on January 24, 2021

    Minerco, Inc the Magic Mushroom Company Announces Sankofa Shareholder and Vision Summit on January 24, 2021

    Dr. Sabrina Black to host Vision Board session Before Shareholder call Las Vegas, Nevada--(Newsfile Corp. - January 13, 2021) - Minerco, Inc. (OTC: MINE) Behind every great accomplishment is a great vision. The first hour of the January 24, 2021 Shareholder call will be a Vision Board Party. Shareholders are encouraged to prepare a vision board for 2021. Minerco will share it's vision and plans to lead the health and wellness industry past current limitations ...